

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.09054803 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.91137478 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.91137478 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.84813875 |
| 5 | leukocyte aggregation (GO:0070486) | 4.70292023 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.64203060 |
| 7 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.62952767 |
| 8 | negative T cell selection (GO:0043383) | 4.59783070 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.54425653 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.45909773 |
| 11 | negative thymic T cell selection (GO:0045060) | 4.44446588 |
| 12 | interferon-gamma production (GO:0032609) | 4.38973504 |
| 13 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.38924535 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.38068525 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.35238850 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.34212203 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.34212203 |
| 18 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.24738470 |
| 19 | positive thymic T cell selection (GO:0045059) | 4.14964215 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07497354 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07497354 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.07497354 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07497354 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 4.07497354 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07497354 |
| 26 | T cell migration (GO:0072678) | 4.07178538 |
| 27 | detection of other organism (GO:0098543) | 4.02119446 |
| 28 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.95638494 |
| 29 | tolerance induction (GO:0002507) | 3.90494767 |
| 30 | detection of bacterium (GO:0016045) | 3.78578346 |
| 31 | response to interleukin-15 (GO:0070672) | 3.78465745 |
| 32 | positive T cell selection (GO:0043368) | 3.78448991 |
| 33 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.70494141 |
| 34 | positive regulation of B cell mediated immunity (GO:0002714) | 3.70494141 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.67730061 |
| 36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.62478559 |
| 37 | positive regulation of isotype switching (GO:0045830) | 3.61318614 |
| 38 | cellular response to interleukin-15 (GO:0071350) | 3.58315685 |
| 39 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.57214432 |
| 40 | myeloid dendritic cell activation (GO:0001773) | 3.56827037 |
| 41 | thymic T cell selection (GO:0045061) | 3.55756295 |
| 42 | neutrophil activation (GO:0042119) | 3.55159334 |
| 43 | negative regulation of interleukin-12 production (GO:0032695) | 3.54047345 |
| 44 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.53586753 |
| 45 | T cell selection (GO:0045058) | 3.53197834 |
| 46 | positive regulation of humoral immune response (GO:0002922) | 3.47818675 |
| 47 | granulocyte activation (GO:0036230) | 3.46875590 |
| 48 | germinal center formation (GO:0002467) | 3.45897921 |
| 49 | response to peptidoglycan (GO:0032494) | 3.42204149 |
| 50 | detection of external biotic stimulus (GO:0098581) | 3.42002912 |
| 51 | regulation of tolerance induction (GO:0002643) | 3.41831672 |
| 52 | detection of molecule of bacterial origin (GO:0032490) | 3.40938597 |
| 53 | myeloid dendritic cell differentiation (GO:0043011) | 3.40811292 |
| 54 | positive regulation of B cell differentiation (GO:0045579) | 3.39837806 |
| 55 | defense response to protozoan (GO:0042832) | 3.36686872 |
| 56 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.36175507 |
| 57 | positive regulation of interleukin-2 production (GO:0032743) | 3.35148103 |
| 58 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.34716222 |
| 59 | immunoglobulin mediated immune response (GO:0016064) | 3.34619380 |
| 60 | regulation of B cell differentiation (GO:0045577) | 3.34555903 |
| 61 | response to type I interferon (GO:0034340) | 3.33769676 |
| 62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.32410150 |
| 63 | type I interferon signaling pathway (GO:0060337) | 3.31670946 |
| 64 | cellular response to type I interferon (GO:0071357) | 3.31670946 |
| 65 | NIK/NF-kappaB signaling (GO:0038061) | 3.30083805 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 3.27605287 |
| 67 | response to protozoan (GO:0001562) | 3.26729843 |
| 68 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.24800310 |
| 69 | regulation of regulatory T cell differentiation (GO:0045589) | 3.23630049 |
| 70 | regulation of B cell mediated immunity (GO:0002712) | 3.22676093 |
| 71 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.21535905 |
| 72 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.20081086 |
| 73 | microglial cell activation (GO:0001774) | 3.19928203 |
| 74 | positive regulation of tolerance induction (GO:0002645) | 3.19798276 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.19391527 |
| 76 | activated T cell proliferation (GO:0050798) | 3.17310571 |
| 77 | positive regulation of DNA recombination (GO:0045911) | 3.16288253 |
| 78 | leukocyte cell-cell adhesion (GO:0007159) | 3.13947574 |
| 79 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.11938219 |
| 80 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11830499 |
| 81 | detection of biotic stimulus (GO:0009595) | 3.11493361 |
| 82 | response to muramyl dipeptide (GO:0032495) | 3.10224735 |
| 83 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.09361588 |
| 84 | * T cell receptor signaling pathway (GO:0050852) | 3.08656175 |
| 85 | regulation of interferon-alpha production (GO:0032647) | 3.06516021 |
| 86 | T cell costimulation (GO:0031295) | 3.05855296 |
| 87 | macrophage activation (GO:0042116) | 3.05240302 |
| 88 | positive regulation of interferon-alpha production (GO:0032727) | 3.05080429 |
| 89 | lymphocyte costimulation (GO:0031294) | 3.04075152 |
| 90 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03773422 |
| 91 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.02386737 |
| 92 | regulation of isotype switching (GO:0045191) | 2.99531437 |
| 93 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.99385493 |
| 94 | regulation of chronic inflammatory response (GO:0002676) | 2.98355739 |
| 95 | B cell mediated immunity (GO:0019724) | 2.97779973 |
| 96 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.97717306 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 2.97534130 |
| 98 | regulation of mast cell degranulation (GO:0043304) | 2.97467450 |
| 99 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.94328561 |
| 100 | neutrophil mediated immunity (GO:0002446) | 2.94301571 |
| 101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.93613504 |
| 102 | * mast cell activation (GO:0045576) | 2.93375611 |
| 103 | regulation of T cell tolerance induction (GO:0002664) | 2.93018171 |
| 104 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.92659055 |
| 105 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91870516 |
| 106 | response to host (GO:0075136) | 2.91870516 |
| 107 | response to host defenses (GO:0052200) | 2.91870516 |
| 108 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.91252057 |
| 109 | regulation of response to interferon-gamma (GO:0060330) | 2.90611559 |
| 110 | T cell homeostasis (GO:0043029) | 2.90146563 |
| 111 | cellular extravasation (GO:0045123) | 2.89488725 |
| 112 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.89173796 |
| 113 | respiratory burst (GO:0045730) | 2.86279671 |
| 114 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.85993046 |
| 115 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.84948504 |
| 116 | B cell receptor signaling pathway (GO:0050853) | 2.83532638 |
| 117 | leukocyte degranulation (GO:0043299) | 2.83377800 |
| 118 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.83206697 |
| 119 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.83206697 |
| 120 | regulation of immunoglobulin secretion (GO:0051023) | 2.82853502 |
| 121 | positive regulation of interferon-gamma production (GO:0032729) | 2.82213277 |
| 122 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.81998757 |
| 123 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.81465024 |
| 124 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.81075977 |
| 125 | cellular response to interferon-beta (GO:0035458) | 2.80763589 |
| 126 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80368302 |
| 127 | negative regulation of innate immune response (GO:0045824) | 2.79723728 |
| 128 | positive regulation of mast cell activation (GO:0033005) | 2.79189751 |
| 129 | mature B cell differentiation (GO:0002335) | 2.78987533 |
| 130 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.78890528 |
| 131 | macrophage activation involved in immune response (GO:0002281) | 2.78720834 |
| 132 | regulation of interleukin-12 production (GO:0032655) | 2.78163590 |
| 133 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.77977646 |
| 134 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.77968663 |
| 135 | T cell proliferation (GO:0042098) | 2.77805931 |
| 136 | response to host immune response (GO:0052572) | 2.77803629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.03432553 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.32077504 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.02976581 |
| 4 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.95689449 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.50847897 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.15140712 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.68453024 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.55339812 |
| 9 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.37845092 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.20737926 |
| 11 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.19817461 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16245062 |
| 13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.09909706 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.06767222 |
| 15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.02411654 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86783824 |
| 17 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.80856252 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.80152127 |
| 19 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.76263907 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.74798837 |
| 21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.66203496 |
| 22 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45890431 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.40765551 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.39488142 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.36094577 |
| 26 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.35283692 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.27019470 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.19358728 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06728371 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06633740 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06078706 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00025000 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.98682219 |
| 34 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.97636643 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95941604 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95840184 |
| 37 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.85848212 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81941663 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73652491 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68642657 |
| 41 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65618106 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63863288 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.63219009 |
| 44 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.60416253 |
| 45 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.58625759 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58572431 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.53882092 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51910454 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51036512 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49972623 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47585565 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43332719 |
| 53 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40565667 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39650412 |
| 55 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39263829 |
| 56 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27956777 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27462653 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25701368 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24853682 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23687140 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20594043 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18176744 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17071766 |
| 64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17002959 |
| 65 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15103893 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14932930 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14737123 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12959209 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11021263 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10299371 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09769653 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07776864 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06211913 |
| 74 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05287881 |
| 75 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05143485 |
| 76 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05142891 |
| 77 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04926510 |
| 78 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01560146 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00507400 |
| 80 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.98263016 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98201818 |
| 82 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95737617 |
| 83 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95205445 |
| 84 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.94566209 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93007630 |
| 86 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.90889543 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90800004 |
| 88 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90081613 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88499027 |
| 90 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.88082641 |
| 91 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87137247 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86989446 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83287427 |
| 94 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.81467153 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81378775 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79914776 |
| 97 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.79268996 |
| 98 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79035707 |
| 99 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.77771610 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75137591 |
| 101 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75131580 |
| 102 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.75097252 |
| 103 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 0.74584042 |
| 104 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.74563744 |
| 105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73523201 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72993666 |
| 107 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72172533 |
| 108 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.72110661 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.71344801 |
| 110 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.70142484 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69693536 |
| 112 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68741608 |
| 113 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.66683437 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64671105 |
| 115 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63657229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.25327303 |
| 2 | MP0005671_abnormal_response_to | 3.93290905 |
| 3 | MP0009785_altered_susceptibility_to | 3.51443878 |
| 4 | MP0003436_decreased_susceptibility_to | 3.46889264 |
| 5 | MP0000685_abnormal_immune_system | 3.25671942 |
| 6 | * MP0003763_abnormal_thymus_physiology | 3.17922570 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.08635897 |
| 8 | * MP0001800_abnormal_humoral_immune | 2.99324313 |
| 9 | MP0006082_CNS_inflammation | 2.97802025 |
| 10 | MP0005387_immune_system_phenotype | 2.93318693 |
| 11 | MP0001790_abnormal_immune_system | 2.93318693 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.89637365 |
| 13 | MP0005025_abnormal_response_to | 2.89061114 |
| 14 | MP0003724_increased_susceptibility_to | 2.79212940 |
| 15 | * MP0002723_abnormal_immune_serum | 2.77310737 |
| 16 | MP0003303_peritoneal_inflammation | 2.75358903 |
| 17 | * MP0002452_abnormal_antigen_presenting | 2.73897226 |
| 18 | MP0002419_abnormal_innate_immunity | 2.72013568 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.64913284 |
| 20 | * MP0001819_abnormal_immune_cell | 2.63844092 |
| 21 | MP0002405_respiratory_system_inflammati | 2.47125609 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.45864289 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.39423982 |
| 24 | * MP0002398_abnormal_bone_marrow | 2.39146658 |
| 25 | * MP0005464_abnormal_platelet_physiology | 2.20436548 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.17609685 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.17422055 |
| 28 | MP0001853_heart_inflammation | 2.16844728 |
| 29 | * MP0000716_abnormal_immune_system | 2.16237885 |
| 30 | MP0002006_tumorigenesis | 2.10160777 |
| 31 | MP0010155_abnormal_intestine_physiology | 2.09387144 |
| 32 | MP0004510_myositis | 2.09007522 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.98596272 |
| 34 | MP0004947_skin_inflammation | 1.94433853 |
| 35 | * MP0002722_abnormal_immune_system | 1.92686438 |
| 36 | MP0001873_stomach_inflammation | 1.87843685 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.87662116 |
| 38 | * MP0002429_abnormal_blood_cell | 1.80562013 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.75879620 |
| 40 | * MP0000703_abnormal_thymus_morphology | 1.75686535 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.69464367 |
| 42 | MP0003866_abnormal_defecation | 1.67156229 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.59503545 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.59503545 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.58295526 |
| 46 | MP0002933_joint_inflammation | 1.51024984 |
| 47 | MP0009278_abnormal_bone_marrow | 1.48765531 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.45366684 |
| 49 | MP0008469_abnormal_protein_level | 1.43740752 |
| 50 | MP0005451_abnormal_body_composition | 1.43651362 |
| 51 | MP0005310_abnormal_salivary_gland | 1.39441365 |
| 52 | MP0000858_altered_metastatic_potential | 1.38860951 |
| 53 | MP0003448_altered_tumor_morphology | 1.35681667 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.34089123 |
| 55 | MP0009764_decreased_sensitivity_to | 1.33560812 |
| 56 | MP0000490_abnormal_crypts_of | 1.29260313 |
| 57 | MP0008004_abnormal_stomach_pH | 1.27440594 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.27157062 |
| 59 | MP0008260_abnormal_autophagy | 1.20876882 |
| 60 | MP0000343_altered_response_to | 1.13002266 |
| 61 | MP0001851_eye_inflammation | 1.12769318 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.08996609 |
| 63 | MP0002132_abnormal_respiratory_system | 1.03183506 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 1.02443404 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.01826446 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.01221911 |
| 67 | MP0008057_abnormal_DNA_replication | 0.97933589 |
| 68 | MP0003690_abnormal_glial_cell | 0.97288629 |
| 69 | MP0005164_abnormal_response_to | 0.94805357 |
| 70 | MP0004883_abnormal_blood_vessel | 0.93771440 |
| 71 | MP0000015_abnormal_ear_pigmentation | 0.88090271 |
| 72 | MP0006054_spinal_hemorrhage | 0.86773796 |
| 73 | MP0003075_altered_response_to | 0.86128592 |
| 74 | MP0009763_increased_sensitivity_to | 0.86028738 |
| 75 | MP0002019_abnormal_tumor_incidence | 0.84838017 |
| 76 | MP0005166_decreased_susceptibility_to | 0.84631851 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.83802706 |
| 78 | MP0000569_abnormal_digit_pigmentation | 0.79465503 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.79127984 |
| 80 | MP0002332_abnormal_exercise_endurance | 0.78925283 |
| 81 | MP0010307_abnormal_tumor_latency | 0.78113152 |
| 82 | MP0005390_skeleton_phenotype | 0.75783723 |
| 83 | MP0004381_abnormal_hair_follicle | 0.72420733 |
| 84 | MP0000604_amyloidosis | 0.71454582 |
| 85 | MP0003828_pulmonary_edema | 0.70475671 |
| 86 | MP0008007_abnormal_cellular_replicative | 0.69888485 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.68205098 |
| 88 | MP0000249_abnormal_blood_vessel | 0.66478336 |
| 89 | MP0000371_diluted_coat_color | 0.65516777 |
| 90 | MP0001663_abnormal_digestive_system | 0.65436806 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.65146590 |
| 92 | MP0002095_abnormal_skin_pigmentation | 0.65133393 |
| 93 | MP0003795_abnormal_bone_structure | 0.65081096 |
| 94 | MP0005023_abnormal_wound_healing | 0.64688149 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.62852646 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.61562786 |
| 97 | MP0010352_gastrointestinal_tract_polyps | 0.58492077 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.57995676 |
| 99 | MP0003693_abnormal_embryo_hatching | 0.57224184 |
| 100 | MP0002254_reproductive_system_inflammat | 0.55601871 |
| 101 | MP0008874_decreased_physiological_sensi | 0.54824618 |
| 102 | MP0004130_abnormal_muscle_cell | 0.53900257 |
| 103 | MP0000920_abnormal_myelination | 0.53761127 |
| 104 | MP0010094_abnormal_chromosome_stability | 0.53402813 |
| 105 | MP0003077_abnormal_cell_cycle | 0.50909596 |
| 106 | MP0008873_increased_physiological_sensi | 0.50708425 |
| 107 | MP0002138_abnormal_hepatobiliary_system | 0.50101887 |
| 108 | MP0000313_abnormal_cell_death | 0.49935917 |
| 109 | MP0005535_abnormal_body_temperature | 0.49822604 |
| 110 | MP0002009_preneoplasia | 0.49701454 |
| 111 | MP0003943_abnormal_hepatobiliary_system | 0.49521296 |
| 112 | MP0003091_abnormal_cell_migration | 0.49038991 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.48942533 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.48578266 |
| 115 | MP0009840_abnormal_foam_cell | 0.46089790 |
| 116 | MP0003453_abnormal_keratinocyte_physiol | 0.45275035 |
| 117 | MP0008058_abnormal_DNA_repair | 0.44975488 |
| 118 | MP0003045_fibrosis | 0.44662522 |
| 119 | MP0000609_abnormal_liver_physiology | 0.43010497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.77340896 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.60586391 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.57792170 |
| 4 | Stomatitis (HP:0010280) | 5.50622038 |
| 5 | Myositis (HP:0100614) | 5.09200083 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.87832730 |
| 7 | T lymphocytopenia (HP:0005403) | 4.62193904 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.59439793 |
| 9 | Abnormality of T cell number (HP:0011839) | 4.55381435 |
| 10 | Optic neuritis (HP:0100653) | 4.39669847 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.39669847 |
| 12 | Orchitis (HP:0100796) | 4.30072980 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.17587336 |
| 14 | Recurrent viral infections (HP:0004429) | 4.14949456 |
| 15 | Abnormality of T cells (HP:0002843) | 3.86990912 |
| 16 | IgM deficiency (HP:0002850) | 3.71795481 |
| 17 | Obstructive lung disease (HP:0006536) | 3.67673963 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.67673963 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.62998685 |
| 20 | Chronic otitis media (HP:0000389) | 3.61351375 |
| 21 | Severe combined immunodeficiency (HP:0004430) | 3.60415439 |
| 22 | Recurrent skin infections (HP:0001581) | 3.58822027 |
| 23 | Vasculitis (HP:0002633) | 3.57678980 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.52538683 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.52416228 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.52416228 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.49185564 |
| 28 | Increased IgM level (HP:0003496) | 3.48660281 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.46114084 |
| 30 | Combined immunodeficiency (HP:0005387) | 3.37473166 |
| 31 | Meningitis (HP:0001287) | 3.37191079 |
| 32 | Recurrent bronchitis (HP:0002837) | 3.28871544 |
| 33 | IgG deficiency (HP:0004315) | 3.28046773 |
| 34 | Leukocytosis (HP:0001974) | 3.24588581 |
| 35 | Pulmonary infiltrates (HP:0002113) | 3.22705628 |
| 36 | Pustule (HP:0200039) | 3.21533035 |
| 37 | Gingivitis (HP:0000230) | 3.09022809 |
| 38 | Chronic diarrhea (HP:0002028) | 3.08402945 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 3.06976801 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.06611455 |
| 41 | B lymphocytopenia (HP:0010976) | 3.04858068 |
| 42 | Abnormality of B cell number (HP:0010975) | 3.04858068 |
| 43 | Nasal polyposis (HP:0100582) | 3.03571271 |
| 44 | Arterial thrombosis (HP:0004420) | 3.02992797 |
| 45 | Petechiae (HP:0000967) | 3.02322787 |
| 46 | Thrombocytosis (HP:0001894) | 3.00464656 |
| 47 | Eosinophilia (HP:0001880) | 2.98525449 |
| 48 | Hemoptysis (HP:0002105) | 2.97420226 |
| 49 | Abnormality of eosinophils (HP:0001879) | 2.94236765 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.91738082 |
| 51 | Thyroiditis (HP:0100646) | 2.90231337 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.89621329 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.89621329 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.89621329 |
| 55 | Abnormality of the prostate (HP:0008775) | 2.77360119 |
| 56 | Granulocytopenia (HP:0001913) | 2.76454747 |
| 57 | Periodontitis (HP:0000704) | 2.73229071 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.73172203 |
| 59 | IgA deficiency (HP:0002720) | 2.72968440 |
| 60 | Gingival bleeding (HP:0000225) | 2.69426809 |
| 61 | Lymphopenia (HP:0001888) | 2.68162958 |
| 62 | Epistaxis (HP:0000421) | 2.66569304 |
| 63 | Abnormality of the nasal mucosa (HP:0000433) | 2.66218977 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.65252600 |
| 65 | Keratoconjunctivitis (HP:0001096) | 2.64229262 |
| 66 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.62319155 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.59480732 |
| 68 | Vacuolated lymphocytes (HP:0001922) | 2.59102454 |
| 69 | Encephalitis (HP:0002383) | 2.59098200 |
| 70 | Gastrointestinal infarctions (HP:0005244) | 2.57677811 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 2.56949253 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.54422089 |
| 73 | Episodic fever (HP:0001954) | 2.50850337 |
| 74 | Abnormality of the fingertips (HP:0001211) | 2.50234324 |
| 75 | Joint swelling (HP:0001386) | 2.50190885 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.49885677 |
| 77 | Lymphoma (HP:0002665) | 2.42413455 |
| 78 | Cellulitis (HP:0100658) | 2.41455850 |
| 79 | Loss of speech (HP:0002371) | 2.39215199 |
| 80 | Chest pain (HP:0100749) | 2.38322995 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.38066777 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34927335 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 2.29633392 |
| 84 | Amyloidosis (HP:0011034) | 2.26860958 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.23662091 |
| 86 | Basal ganglia calcification (HP:0002135) | 2.22931041 |
| 87 | Colitis (HP:0002583) | 2.20567447 |
| 88 | Increased serum ferritin (HP:0003281) | 2.19060122 |
| 89 | Hypochromic anemia (HP:0001931) | 2.18832139 |
| 90 | Abnormality of the pleura (HP:0002103) | 2.16912320 |
| 91 | Polyneuropathy (HP:0001271) | 2.16650324 |
| 92 | Vertigo (HP:0002321) | 2.14274535 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.12774556 |
| 94 | Purpura (HP:0000979) | 2.12015383 |
| 95 | Hypoplasia of the thymus (HP:0000778) | 2.10647341 |
| 96 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10381284 |
| 97 | Acute myeloid leukemia (HP:0004808) | 2.10305707 |
| 98 | Sepsis (HP:0100806) | 2.09040623 |
| 99 | Increased IgE level (HP:0003212) | 2.08264782 |
| 100 | Gangrene (HP:0100758) | 2.08139366 |
| 101 | Pulmonary embolism (HP:0002204) | 2.08112323 |
| 102 | Urticaria (HP:0001025) | 2.08030949 |
| 103 | Osteomyelitis (HP:0002754) | 2.07701791 |
| 104 | Agammaglobulinemia (HP:0004432) | 2.04742874 |
| 105 | Amaurosis fugax (HP:0100576) | 2.03294721 |
| 106 | Recurrent sinusitis (HP:0011108) | 2.02015478 |
| 107 | Keratitis (HP:0000491) | 2.01015199 |
| 108 | Prostate neoplasm (HP:0100787) | 2.00493263 |
| 109 | Abnormal platelet function (HP:0011869) | 1.99666955 |
| 110 | Impaired platelet aggregation (HP:0003540) | 1.99666955 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 1.98800656 |
| 112 | Cheilitis (HP:0100825) | 1.98790568 |
| 113 | Recurrent pneumonia (HP:0006532) | 1.98719844 |
| 114 | Gastrointestinal stroma tumor (HP:0100723) | 1.98444227 |
| 115 | Hematochezia (HP:0002573) | 1.97817296 |
| 116 | Abnormality of the endocardium (HP:0004306) | 1.97207659 |
| 117 | Slow saccadic eye movements (HP:0000514) | 1.96803094 |
| 118 | Glomerulopathy (HP:0100820) | 1.95885893 |
| 119 | Peritonitis (HP:0002586) | 1.95565431 |
| 120 | Anorexia (HP:0002039) | 1.95401058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TXK | 3.87783514 |
| 2 | * MAP4K1 | 3.80737069 |
| 3 | MAP3K14 | 3.30751784 |
| 4 | JAK3 | 3.27973291 |
| 5 | BLK | 2.93491445 |
| 6 | IRAK4 | 2.76711893 |
| 7 | IKBKE | 2.75813297 |
| 8 | TYK2 | 2.75159441 |
| 9 | KIT | 2.56862660 |
| 10 | TBK1 | 2.54413427 |
| 11 | PRPF4B | 2.50106432 |
| 12 | * ZAP70 | 2.44507478 |
| 13 | ITK | 2.42721688 |
| 14 | TEC | 2.35296065 |
| 15 | IKBKB | 2.06435606 |
| 16 | BTK | 2.05640841 |
| 17 | STK10 | 1.93413814 |
| 18 | IRAK3 | 1.90874570 |
| 19 | JAK1 | 1.86523963 |
| 20 | CSK | 1.81872465 |
| 21 | * LCK | 1.77486558 |
| 22 | PIM2 | 1.68069668 |
| 23 | RIPK4 | 1.67340987 |
| 24 | FGFR4 | 1.67095925 |
| 25 | * SYK | 1.63211306 |
| 26 | CSF1R | 1.52992086 |
| 27 | * HCK | 1.49960432 |
| 28 | TGFBR2 | 1.48984045 |
| 29 | CHUK | 1.44238566 |
| 30 | NME2 | 1.41037059 |
| 31 | PIM1 | 1.38810279 |
| 32 | TAOK3 | 1.37587835 |
| 33 | FGFR3 | 1.32642904 |
| 34 | MAP2K3 | 1.32341156 |
| 35 | MAP3K13 | 1.27447059 |
| 36 | RPS6KA4 | 1.25219139 |
| 37 | FES | 1.24919302 |
| 38 | NLK | 1.21528283 |
| 39 | * LYN | 1.21157906 |
| 40 | CLK1 | 1.20599414 |
| 41 | MAP3K1 | 1.15005545 |
| 42 | FLT3 | 1.13685639 |
| 43 | NEK9 | 1.13239986 |
| 44 | EPHB1 | 1.05948764 |
| 45 | GRK6 | 1.02738536 |
| 46 | MST4 | 1.01246550 |
| 47 | JAK2 | 0.99817713 |
| 48 | ERN1 | 0.95925965 |
| 49 | IRAK2 | 0.94472249 |
| 50 | EEF2K | 0.93602577 |
| 51 | KDR | 0.91983226 |
| 52 | MARK3 | 0.89507644 |
| 53 | SIK3 | 0.85613136 |
| 54 | CAMKK2 | 0.84209690 |
| 55 | CDC42BPA | 0.79819879 |
| 56 | MAP3K11 | 0.79434048 |
| 57 | PRKCQ | 0.78767565 |
| 58 | LRRK2 | 0.70209677 |
| 59 | SIK2 | 0.69846652 |
| 60 | PIK3CG | 0.69200644 |
| 61 | EPHA3 | 0.67893880 |
| 62 | MARK2 | 0.67039344 |
| 63 | TGFBR1 | 0.66014431 |
| 64 | ADRBK2 | 0.64492788 |
| 65 | MAPK7 | 0.63796084 |
| 66 | CDK12 | 0.62858939 |
| 67 | MAP3K12 | 0.62726202 |
| 68 | STK4 | 0.62341402 |
| 69 | KSR2 | 0.59682174 |
| 70 | MAPK12 | 0.59600319 |
| 71 | TNK2 | 0.58736518 |
| 72 | CAMKK1 | 0.58574558 |
| 73 | MAP3K10 | 0.58324933 |
| 74 | IRAK1 | 0.56354751 |
| 75 | RIPK1 | 0.55636347 |
| 76 | CDK6 | 0.52118113 |
| 77 | MOS | 0.51883478 |
| 78 | TAOK1 | 0.51641530 |
| 79 | YES1 | 0.51384132 |
| 80 | MAP2K6 | 0.51338768 |
| 81 | CDK4 | 0.50204946 |
| 82 | MATK | 0.44929225 |
| 83 | PDPK1 | 0.44894082 |
| 84 | RPS6KA6 | 0.44535498 |
| 85 | PRKCH | 0.44209530 |
| 86 | PKN2 | 0.42532678 |
| 87 | EIF2AK2 | 0.42500861 |
| 88 | MAPKAPK2 | 0.41506748 |
| 89 | ABL1 | 0.41339464 |
| 90 | TRPM7 | 0.41295946 |
| 91 | RPS6KA5 | 0.40800064 |
| 92 | PDGFRB | 0.40754160 |
| 93 | TYRO3 | 0.40584078 |
| 94 | EGFR | 0.39774378 |
| 95 | MAP3K3 | 0.38665754 |
| 96 | TAOK2 | 0.38450433 |
| 97 | PDK1 | 0.37816658 |
| 98 | PRKCD | 0.37465614 |
| 99 | MAPK4 | 0.36049191 |
| 100 | HIPK2 | 0.35564042 |
| 101 | TSSK6 | 0.35476747 |
| 102 | PTK6 | 0.35210789 |
| 103 | PRKD2 | 0.34997826 |
| 104 | FGR | 0.34419284 |
| 105 | GRK7 | 0.33992396 |
| 106 | MAP3K6 | 0.33700462 |
| 107 | ATR | 0.32785629 |
| 108 | FYN | 0.31937587 |
| 109 | SGK3 | 0.31681866 |
| 110 | MAP3K7 | 0.31328516 |
| 111 | MAPK11 | 0.30804203 |
| 112 | MAP3K5 | 0.30438627 |
| 113 | ACVR1B | 0.28983799 |
| 114 | BRD4 | 0.28789264 |
| 115 | RPS6KL1 | 0.28344873 |
| 116 | RPS6KC1 | 0.28344873 |
| 117 | BMPR2 | 0.28013404 |
| 118 | MAPK3 | 0.27057977 |
| 119 | TESK2 | 0.26341799 |
| 120 | DAPK2 | 0.24461548 |
| 121 | DYRK1B | 0.24072387 |
| 122 | MAP3K8 | 0.24045127 |
| 123 | ALK | 0.23912839 |
| 124 | TRIB3 | 0.23531024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.41469577 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.19993567 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.11235758 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.07879291 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.93681934 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.82471647 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.62390021 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.53238647 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.42121534 |
| 10 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.30445586 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.26353883 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.15571600 |
| 13 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14293568 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13347758 |
| 15 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.10296452 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.02773979 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00302323 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.98954285 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.97037748 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.92813851 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.86056451 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82446490 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.77682791 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.73212027 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72944947 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.66263778 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.63804253 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.56454847 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.53797408 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.53289565 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.51614440 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51535081 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.51264619 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32830971 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30855689 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29150775 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.27351380 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22602644 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.22024341 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21741262 |
| 41 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19087697 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.18484131 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.17530422 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04165357 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98322165 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94800358 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89449858 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.87862172 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86986877 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.86395002 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85681035 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80289203 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77219415 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76173686 |
| 55 | * Platelet activation_Homo sapiens_hsa04611 | 0.75090849 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.74918451 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69939239 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69040450 |
| 59 | DNA replication_Homo sapiens_hsa03030 | 0.67568777 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67122586 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65777200 |
| 62 | Base excision repair_Homo sapiens_hsa03410 | 0.60949148 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.57847962 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.56743707 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56003884 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55865936 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53389739 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51527502 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48652276 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47436306 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47079166 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45284213 |
| 73 | Ribosome_Homo sapiens_hsa03010 | 0.43998828 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43761304 |
| 75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43737657 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43276706 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.42292853 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41669998 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41071283 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37578215 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36716941 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36400432 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36329102 |
| 84 | Mismatch repair_Homo sapiens_hsa03430 | 0.35029317 |
| 85 | Homologous recombination_Homo sapiens_hsa03440 | 0.34971293 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34583766 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34494800 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.34227958 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33033973 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32492088 |
| 91 | Spliceosome_Homo sapiens_hsa03040 | 0.32371944 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.32026958 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29065346 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28580339 |
| 95 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.27455257 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27317310 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26859043 |
| 98 | RNA degradation_Homo sapiens_hsa03018 | 0.26298313 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.26104030 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25369972 |
| 101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.25335955 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25240514 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.24573823 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24019658 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23996137 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23410493 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23025137 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22371776 |
| 109 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.22123667 |
| 110 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.21773088 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.21575739 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19509994 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.19409764 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.18479089 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17101505 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.14912912 |
| 117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.14632821 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14177082 |

